Form 8-K · Current report
Albemarle Corporation 8-K, filed Jul 23, 2026
- Filed
- CIK
- 0000915913
- Accession no.
- 0000915913-26-000095
Summary
Albemarle Corporation appointed Eduardo Bartolomeo, former CEO of Vale S.A., as an independent member of its board effective July 21, 2026, and to its Audit & Finance and Safety, Sustainability, Operations & Capital committees.
Key points
- Bartolomeo most recently served as CEO of Vale S.A. from 2019 to 2024.
- He will receive a $120,000 annual retainer and an annual restricted stock grant of $170,000 under the non-employee director compensation program.
- He holds MBAs from MIT and KU Leuven and a metallurgical engineering degree from Universidade Federal Fluminense, and serves on the board of Boston Metal, Inc.
- Albemarle Chairman and CEO Kent Masters said Bartolomeo's mining, metals and logistics experience will be valuable as the company executes its strategy.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) Effective as of July 21, 2026, the Board of Directors (the “Board”) of Albemarle Corporation (the “Company”) appointed Mr. Eduardo De Salles Bartolomeo as an independent member of the Board. Mr. Bartolomeo has been appointed to the Board’s Audit and Finance Committee and Safety, Sustainability, Operations & Capital Committee. In accordance with our non-employee director compensation program, Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.